Induction of human breast cancer cell apoptosis from G2/M preceded by stimulation into the cell cycle by Z-1,1-dichloro-2,3-diphenylcyclopropane

Biochemical Pharmacology

Volumn 57, Issue 1, 1999, Pages 97-110

  Balachandran, Raghavan ^a   Ter Haar, Ernst ^a,e   Yalowich, Jack C ^b,d   Welsh, Manda J ^a   Grant, Stephen G ^a,c,d   Day, Billy W ^a,b,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b Dept of Pharmaceutical Sciences ^*  (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Analog II; Bromodeoxyuridine; Cycloheximide; Flow cytometry; Hoechst 33342; Pulsed field gel electrophoresis

Indexed keywords

1,1 DICHLORO 2,3 DIPHENYLCYCLOPROPANE; ANTINEOPLASTIC AGENT; BROXURIDINE; CYCLOHEXIMIDE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; ESTROGEN BINDING; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZIMIDAZOLES; BREAST NEOPLASMS; CELL CYCLE; CELL NUCLEUS; DNA FRAGMENTATION; DNA, NEOPLASM; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; G2 PHASE; HUMANS; MITOSIS; MOLECULAR STRUCTURE; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0032919240     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00289-5     Document Type: Article

References (46)

1. Pento J.T., Magarian R.A., King M.M. A comparison of the efficacy for antitumor activity of the non-steroidal antiestrogens Analog II and tamoxifen in DMBA-induced rat mammary tumors. Cancer Lett. 15:1982;261-269.
2. King M.M., Pento J.T., Magarian R.A., Brueggemann G.L. The interaction of dietary fat and antiestrogen treatment on DMBA-induced mammary tumors in the rat. Nutr Cancer. 7:1985;239-249.
3. King M.M., Magarian R.A., Terao J., Brueggemann G.L. Effects of nonsteroidal antiestrogens, analog II and tamoxifen, on a metastatic transplantable rat mammary tumor. J Natl Cancer Inst. 74:1985;447-451.
4. Day B.W., Magarian R.A., Pento J.T., Jain P.T., Mousissian G.K., Meyer K.L. Synthesis and biological evaluation of 1,1-dichloro-2,2,3-triarylcyclopropanes as pure antiestrogens. J Med Chem. 34:1991;842-851.
5. Pento J.T., Magarian R.A., Wright R.J., King M.M., Benjamin E.J. Non-steroidal estrogens and antiestrogens. Biological activity of cyclopropyl analogs of stilbene and stilbenediol. J Pharm Sci. 70:1981;339-343.
6. ter Haar E., Day B.W. Cytostatic and cytotoxic action of Z-1,1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines. Anticancer Res. 16:1996;1107-1115.
7. Rajah T.T., Pento J.T. The mutagenic potential of antiestrogens at the HPRT locus in V79 cells. Res Commun Mol Pathol Pharmacol. 89:1995;85-92.
8. ter Haar E., Hamel E., Balachandran R., Day B.W. Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane Type II estrogen binding sites and tubulin . Anticancer Res. 17:1997;1861-1870.
9. Dive C., Evans C.A., Whetton A.D. Induction of apoptosis - New targets for cancer chemotherapy. Semin Cancer Biol. 3:1992;417-427.
10. Kerr J.F.R., Winterford C.M., Harmon B.V. Apoptosis Its significance in cancer and cancer therapy . Cancer. 73:1994;2013-2016.
11. Hickman J.A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11:1992;121-139.
12. Cotter T.G., Glynn J.M., Echeverri F., Green D.R. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res. 12:1992;773-780.
13. Dive C., Hickman J.A. Drug target interactions Only the first step in the commitment to a programmed cell death . Br J Cancer. 64:1992;192-196.
14. Martin S.J. Apoptosis Suicide, execution or murder? Trends Cell Biol. 3:1993;141-144.
15. Martin S.J., Green D.R., Cotter T.G. Dicing with death Dissecting the components of the apoptosis machinery . Trends Biochem Sci. 19:1994;26-30.
16. Compton M.M. A biochemical hallmark of apoptosis Internucleosomal degradation of the genome . Cancer Metastasis Rev. 11:1992;105-109.
17. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 124:1994;619-626.
18. Oberhammer F., Wilson J.W., Dive C., Morris I.D., Hickman J.A., Wakeling A.E., Walker P.R., Sikorska M. Apoptotic death in epithelial cells Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation . EMBO J. 12:1993;3679-3684.
19. Rusnak J.M., Calmels T.P.G., Hoyt D.G., Kondo Y., Yalowich J.C., Lazo J.S. Genesis of discrete high order DNA fragments in apoptotic human prostate carcinoma cells. Mol Pharmacol. 49:1996;244-252.
20. Walker P.R., Kokileva L., Le Blanc J., Sikorska M. Detection of the initial stages of DNA fragmentation in apoptosis. Biotechniques. 15:1993;105-109.
21. Brown D.G., Sur X.M., Cohen G.M. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J Biol Chem. 268:1993;3037-3039.
22. Huang P., Ballal K., Plunkett W. Biochemical characterization of the protein activity responsible for high molecular weight DNA fragmentation during drug-induced apoptosis. Cancer Res. 57:1997;3407-3414.
23. Fan S., Smith M.L., Rivet D.J. II, Duba D., Zhan Q., Kohn K.W., Fornace A.J. Jr. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res. 55:1995;1649-1654.
24. Kyprianou N., English H.F., Davidson N.E., Isaacs J.T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 51:1991;162-166.
25. Armstrong D.K., Kaufmann S.H., Ottaviano Y.L., Furuya Y., Buckley J.A., Isaacs J.T., Davidson N.E. Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res. 54:1994;5280-5283.
26. Armstrong D.K., Isaacs J.T., Ottaviano Y.L., Davidson N.E. Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468. Cancer Res. 52:1992;3418-3424.
27. McCloskey D.E., Kaufmann S.H., Prestigiacomo L.J., Davidson N.E. Paclitaxel induces programmed cell death in MDA-MB-468 human breast cancer cells. Clin Cancer Res. 2:1996;847-854.
28. Magarian R.A., Benjamin E.J. Syntheses of cyclopropyl analogs of stilbene and stilbenediol as possible antiestrogens. J Pharm Sci. 64:1975;1626-1632.
29. Jonnalagadda S.S., ter Haar E., Hamel E., Lin C., Magarian R.A., Day B.W. Synthesis and biological evaluation of 1,1-dichloro-2,3-diarylcyclopropanes as antitubulin and anti-breast cancer agents. Bioorg Med Chem. 5:1997;715-722.
30. Dolbeare F., Gratzner H.G., Pallavicini M.G., Gray J.W. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA. 80:1983;5573-5577.
31. Hamel E. Antimitotic agents and their interactions with tubulin. Med Res Rev. 16:1996;207-231.
32. Balachandran R., ter Haar E., Welsh M.J., Grant S.G., Day B.W. The microtubule-stabilizing agent (+)-discodermolide induces apoptosis in human breast carcinoma cells - Preliminary comparisons to paclitaxel. Anticancer Drugs. 9:1998;67-76. [erratum pp. 369-370].
33. Widschwendter M., Daxenbichler G., Dapunt O., Marth C. Effects of retinoic acid and γ-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells. Cancer Res. 55:1995;2135-2139.
34. Widschwendter M., Daxenbichler G., Culig Z., Michel S., Zeimet A.G., Mörtl M.G., Widschwendter A., Marth C. Activity of retinoic acid receptor-γ selectively binding retinoids alone and in combination with interferon-γ in breast cancer cell lines. Int J Cancer. 71:1997;497-504.
35. Betz N.A., Fattaey H.K., Westhoff B.A., Paulsen A.Q., Johnson T.C. CeReS-18, a novel cell surface sialoglycopeptide, induces cell cycle arrest and apoptosis in a calcium-sensitive manner. Breast Cancer Res Treat. 42:1997;137-148.
36. Ji H.J., Zhang Q.Q., Leung B.S. Survey of oncogene and growth factor/receptor gene expression in cancer cells by intron-differential RNA/PCR. Biochem Biophys Res Commun. 170:1990;569-575.
37. Yu W.C., Leung B.S., Gao Y.L. Effects of 17β-estradiol on progesterone receptors and the uptake of thymidine in human breast cancer cell line CAMA-1. Cancer Res. 41:1981;5004-5009.
38. Turley J.M., Fu T., Ruscetti F.W., Mikovits J.A., Bertolette D.C. III, Birchenall-Roberts M.C. Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res. 57:1997;881-890.
39. Soule H.D., Maloney T.M., Wolman S.R., Peterson W.D. Jr, Brenz R., McGrath C.M., Russo J., Pauley R.J., Jones R.F., Brooks S.C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50:1990;6075-6086.
40. Liebman J., Cook J.A., Teague D., Fisher J., Mitchell J.B. Cycloheximide inhibits the cytotoxicity of paclitaxel (Taxol). Anticancer Drugs. 5:1994;287-292.
41. Blagosklonny M.V., El-Deiry W.S. Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells. Int J Cancer. 75:1998;933-940.
42. Dees C., Askari M., Foster J.S., Ahamed S., Wimalasena J. DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle. Mol Carcinog. 18:1997;107-114.
43. Zava D.T., Blen M.A., Duwe G. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ Health Perspect. 105:(Suppl 3):1997;637-645.
44. Tishler R.B., Lamppu D.M. The interaction of taxol and vinblastine with radiation induction of p53 and p21 WAF1/CIP1. Br J Cancer. 74:(Suppl 27):1996;S82-S85.
45. 1 arrest. Cancer Res. 58:1998;396-401.
46. Balachandran R, Grant SG, Welsh MJ and Day BW, Increased sensitivity of the antiestrogen-resistant MCF-7/LY2 human breast carcinoma cell line to apoptosis induced by the novel microtubule-stabilizing agent (+)-discodermolide. Breast J 4: in press, 1998.